Sudden Illness in Atlanta

Last year, popular actor Jamie Foxx experienced a mysterious health issue that kept him out of sight for 20 days. The incident occurred in April 2023, while Foxx was in Atlanta shooting for Netflix’s film “Back in Action.” Foxx’s daughter, Corinne, referred to the event as a “medical complication,” the specifics of which have remained undisclosed until recently.

Foxx Shares His Experience

The Oscar-winning actor broke his silence this week through a video shared on TikTok. The clip, which caught the public’s attention, soon circulated on other social media platforms. In the footage spotted over the weekend in downtown Phoenix, Foxx narrates his sudden health debacle. He recalls suffering a “bad headache” on April 11, 2023, and asking a friend for an Advil. After that, he remembers nothing. He simply “woke up 20 days later with no memory of what happened”.

Medical Intervention

As Foxx reveals, his sister and daughter took him to see a doctor following his plight. He was administered a cortisone shot, a commonly used remedy for pain and inflammation. However, their visit led to more questions than answers. Doctors warned Foxx, “something’s going on up there,” while pointing to his head. He refused to discuss the details on camera, alluding to a serious underlying condition.

Foxx’s Previous Statements

Foxx had vaguely discussed his ordeal in a social media video last July. He termed it something so intense he “never thought he would go through.” He also mentioned a challenging recovery journey filled with “potholes”. He also hinted that he was reluctant to share the specifics to protect his image, stating, “I just didn’t want you to see me like that.”

Road to Recovery

In a social media post in August, Foxx updated his fans about his recuperation process. He captioned a sequence of pictures with “finally startin to feel like myself”. He described his recovery journey as an “unexpected dark journey” but now he could “see the light”.

Foxx Continues to Tease More Information

During the Special Achievement Awards luncheon at the African American Film Critics Association, Foxx hinted at disclosing more about his health scare. Charismatic as always, Foxx expressed his intent to share his story in a humorous way on stage. He called it a return to his “standup sort of roots”.

Looking Ahead

The film “Back in Action”, starring Foxx and marking his onscreen reunion with Cameron Diaz, is under post-production. It is scheduled to release later this week. All eyes are now on Foxx. Fans and well-wishers wait anxiously for his return to the screen and for more insights into his mysterious health scare.

Many working professionals like Cori Lint lead seemingly content lives, splashed with hobbies, friends, and rewarding careers. But, suddenly without warning, they’re ambushed by panic attacks and suicidal thoughts. Health professionals had diagnosed Cori, a software engineer and part-time cellist, with anxiety and depression. But she felt there was something more lurking beneath these diagnosis labels.

Finding the Missing Link

It wasn’t until 2022 that Cori discovered a cyclical pattern to her recurring dark bouts. Each time, they coincided with her menstrual period. This prompted her further research where she stumbled upon what appeared to be an accurate description of her experiences. It was premenstrual dysphoric disorder or PMDD. Suddenly, everything made sense.

What is PMDD?

PMDD is our body’s severe adverse reaction toward the natural hormonal fluctuations experienced in the week or two leading up to the menstrual cycle. The symptoms are anything but mild, encompassing irritability, anxiety, depression, and sudden mood changes. Physical discomforts like fatigue, joint and muscle pain, and changes in appetite and sleep patterns can also accompany these mental disturbances.

The Debilitating Effect of PMDD

Unlike premenstrual syndrome (PMS), PMDD is life-altering. Reports suggest those affected could face nearly four years of disability throughout their lifetimes. Despite researchers estimating PMDD to affect about 5% of menstruating individuals, equivalent to the percentage of women with diabetes, this disorder remains relatively unknown, even among healthcare providers.

A 2022 survey published in the Journal of Women’s Health unveiled that over a third of PMDD patients claimed their family doctors had little knowledge about the disorder or its treatment. About 40% echoed the same for their mental health therapists.

The Push for Attention

Reproductive mental health has taken a backstage too often in health studies and discussions, says Jaclyn Ross, a clinical psychologist specializing in premenstrual disorders. The chances of misdiagnosis are high when menstrual cycles aren’t taken into account. The story stands testament to this argument, with multiple women, like Jenna Tingum, a med student from Florida, only realizing they might have PMDD after learning about it online.

PMDD’s Enigma and Treatment Options

Despite health professionals recognizing PMDD relatively recently, the causes are still largely unknown, and treatment options remain limited. It wasn’t until 2013 that PMDD made its way into the Diagnostic and Statistical Manual, the bible for medical professionals diagnosing psychiatric conditions. The World Health Organization officially acknowledged it only in 2019.

Moreover, PMDD has serious implications. One study disclosed that 72% of PMDD respondents confessed to having harbored suicidal thoughts, with 34% having attempted suicide. In contrast, these numbers stand at 3% for the general population.

There are three main treatment choices for PMDD, according to Rachel Carpenter, medical director of reproductive psychiatry at the University of Florida–Jacksonville College of Medicine. These include antidepressants, hormonal birth control, and a mix of talk therapy and cycle awareness.

The Need for More Conversations

The lack of conversations around periods has often delayed diagnosis for women. Most of them, like Cori Lint and Jenna Tingum, discovered they had PMDD through personal research and not through professional medical intervention.

While battling PMDD can be challenging, individuals affected have found comfort in tracking their cycle, creating personal resilience strategies, and reading about other people’s experiences. These techniques help them accept their condition and reassure them they aren’t alone.

The hope is that society can create more awareness about PMDD and stimulate more open conversations about issues related to periods and women’s health. With more studies, we can move toward better understanding and treating this mysterious condition. It’s time we step up and shine a light on PMDD, helping millions who silently suffer and struggle to understand what’s happening to them.

In a recent episode of the KFF Health News’ weekly health policy podcast, “What the Health?” Julie Rovner, chief Washington correspondent, and legal director of the National Health Law Program, Sarah Somers, addressed key health policy issues that grasped the Supreme Court’s attention this past year.

Health Policy Shakers from the Supreme Court

Broadly, these areas included governmental functioning, abortion-centric issues, and other health matters that were under the judicial lens. Notably, the justices of the Supreme Court were confronted with two abortion cases and a case involving the ongoing opioid epidemic.

Governmental Functioning and Policy Involvement

In terms of governmental functioning, the justices had to address two cases. One case, Loper Bright Enterprises v. Raimondo, challenged the “Chevron doctrine” which dictates that the courts must respect the expertise of federal agencies when interpreting laws from Congress. The other case, Corner Post Inc. v. Board of Governors of the Federal Reserve System, questioned the time limit for filing a case against a federal agency’s actions.

Abortion-Based Matters

On the abortion front, the court wrestled with the cases of Food and Drug Administration v. Alliance for Hippocratic Medicine and Moyle v. United States. The former contested the FDA’s approval of the abortion pill mifepristone. The latter debated whether the federal Emergency Medical Treatment and Active Labor Act (EMTALA) can override Idaho’s near-complete abortion ban during a medical emergency involving a pregnant woman.

Digging into Other Health Concerns

Other health-related issues taken up by the court included Harrington v. Purdue Pharma, which questioned whether federal bankruptcy law can protect a company from future claims without the consent of all claimants. The City of Grants Pass v. Johnson case dealt with a human rights issue, addressing whether banning public sleeping is cruel and unusual punishment for homeless people.

The Knock-On Effect of These Cases

Exploring the ramifications of these cases, the panel particularly noted the potential impact of the Loper Bright Enterprises v. Raimondo and Corner Post Inc. v. Board of Governors cases. The repercussion of ruling against the previously established “Chevron doctrine” could dramatically alter how the federal government oversees health care and other policy areas.

Dissenters argue that overturning the Chevron doctrine would allow courts to prioritize their interpretation over that of experts in the respective federal agencies. This case could have a widespread impact on various domains including health, environment, and transportation.

Furthermore, the Corner Post Inc. case opens up litigation avenues for entities with ample resources to challenge long-standing regulations, potentially creating an uneven platform for other stakeholders.

Navigating Health-Adjacent Issues

In addition to intense health policy cases, the Supreme Court also considered ‘health care-adjacent’ subjects. One such case was a bankruptcy settlement issue involving Purdue Pharma, the producer of the high addictive opioid OxyContin. The court ruled against a settlement, expressing concern over the settlement’s efficacy in compensating the debtors or future victims.

The court also ruled on a case that potentially impacts public health. It stated that cities could enforce bans against public sleeping even if the individuals have no housing or access to shelter.

Looking Ahead

Concluding the discussion, Somers noted that the judgement against the Chevron doctrine and the Corner Post Inc. case could potentially cause a significant shift in health policy. This judgment could affect multiple areas ranging from controversial topics such as abortion and family planning to more practical logistics like patient billing and hospital functioning.

Overall, the cases reviewed this term underline the court’s evolving role in health policy and adjacent areas, hinting towards future uncertainties as checks and balances continue to oscillate.

To keep up-to-date with how these changes unfold and their potential effect on health policy, stay tuned to the weekly podcast “What the Health?”